Relevance of UCSF respiratory RNA mNGS original-testing sensitivity protocol to "Select an RNA pathogen-detection workflow for diagnostic testing"
- Use case
- Select an RNA pathogen-detection workflow for diagnostic testing
- Assessed by
- UCSF respiratory RNA mNGS original-testing sensitivity protocol
- Relevance
- Proxy evidence
- Endpoint
- Sensitivity against original clinical respiratory-virus-panel testing (103/110, 93.6%) for RNA mNGS on a residual-sample pre-DTCA mixed respiratory-target cohort, adenovirus transcripts included
Sensitivity against original clinical RVP testing (RNA extraction, DNase treatment, cDNA synthesis; mixed respiratory-virus target panel including transcriptionally detected adenovirus) is a proxy for the declared RNA-pathogen diagnostic-accuracy decision: the specimen prep is an RNA workflow, not a mixed DNA/RNA sample-prep comparison, and this is not an RNA-virus-only subgroup score. The conflicting composite PPA figure (98.7%, 110.5/113) is excluded.
1 reviewed evaluation
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
15 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Sensitivity against original clinical respiratory-virus-panel testing (103/110, 93.6%) for RNA mNGS on a residual-sample pre-DTCA mixed respiratory-target cohort, adenovirus transcripts included Context-only references | Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:amp-20261007-rna-pathogens-protocol Context-only references | Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations6 values
| Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records5 values
| Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale Sensitivity against original clinical RVP testing (RNA extraction, DNase treatment, cDNA synthesis; mixed respiratory-virus target panel including transcriptionally detected adenovirus) is a proxy for the declared RNA-pathogen diagnostic-accuracy decision: the specimen prep is an RNA workflow, not a mixed DNA/RNA sample-prep comparison, and this is not an RNA-virus-only subgroup score. The conflicting composite PPA figure (98.7%, 110.5/113) is excluded. Context-only references | Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Reason Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365). Context-only references | Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relevance proxy Context-only references | Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Revision 1 Context-only references | Tan et al., Nature Communications 15, 9016 (2024) amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Version: Tan et al., Nature Communications 15, 9016 (2024) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Tan et al., Nature Communications 15, 9016 (2024) · Original source · Tan et al., Nature Communications 15, 9016 (2024)
Technical metadata and extraction receipts
Stable ID: use-case-mapping-amp-20261007-issue14
- field
- links:assessed_by:amp-20261007-rna-pathogens-protocol
- value
- amp-20261007-rna-pathogens-protocol
- relevance
- proxy
- endpoint
- Sensitivity against original clinical respiratory-virus-panel testing (103/110, 93.6%) for RNA mNGS on a residual-sample pre-DTCA mixed respiratory-target cohort, adenovirus transcripts included
- rationale
- Sensitivity against original clinical RVP testing (RNA extraction, DNase treatment, cDNA synthesis; mixed respiratory-virus target panel including transcriptionally detected adenovirus) is a proxy for the declared RNA-pathogen diagnostic-accuracy decision: the specimen prep is an RNA workflow, not a mixed DNA/RNA sample-prep comparison, and this is not an RNA-virus-only subgroup score. The conflicting composite PPA figure (98.7%, 110.5/113) is excluded.
- constraints
- Inspect every linked evaluation's source locator and preserved conflicts before citing a result.; Do not combine this mapping's evaluations with any other protocol's results.
- limitations
- RNA-only specimen preparation supports RNA pathogen-detection workflow; tested target mix includes adenovirus, a DNA virus detected via transcription. Do not describe the 93.6% as a pure RNA-virus-only subgroup score.; Multiple detected targets are weighted so each specimen contributes one observation; out-of-panel mNGS positive calls are not counted as false positives.; Positive-specimen BAL/swab count disagreement in Results vs Methods remains unresolved; total 110 positives and 81 negatives agree.; No confidence interval extracted for original sensitivity. After selective discrepancy adjudication, report PPA/NPA rather than sensitivity; DTCA measurements must remain separate.; No foundation model or independent external replication; clinical residual-sample validation study supplies conventional baseline evidence.; Post-DTCA printed PPA98.7% (110.5/113) is arithmetically inconsistent; no DTCA endpoint selected or corrected.
- revision
- 1
- reason
- Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365).
- citation locators
- source id: amp-20261007-rna-pathogens-source; locator: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- source locator
- amp-20261007-rna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- review
- method: automated-source-review; reviewer: codex; claude-sonnet; reviewer note: Claude Sonnet AMP-integration worker, bounded transcription of Codex-checked primary values; independently reviewed by Codex (workbench/amp-supervision/primary-review.md, integration-review-corrections.md); reviewed at: 2026-10-07T13:38:59Z; note: Bounded primary-source transcription, independently Codex-checked. No new model execution, independent experimental reproduction, qualified human scientific review or clinical validation.
- reviewed evaluations
- amp-20261007-rna-pathogens-evaluation
- pins
- record id: amp-20261007-rna-pathogens-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: 63b089b5e45283ca4551dec6e0306735252743f3498082ccb02686a71262c435; record id: amp-20261007-rna-pathogens-protocol; fields: status; name; description; facets; source_ids; links; attributes; sha256: ffbf0e70afb8de17ff480a05b0186f5b55a85ea3c057affa28920f2a0557c48c; record id: amp-20261007-rna-pathogens-result; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 773011aed61b7bfc4c957b94521a384a1744e3ca075e7815013a99a6f15cfef2; record id: amp-20261007-rna-pathogens-source; fields: status; attributes.artifact_sha256; sha256: a75e7005f450b91837cce907a0aac78073361b0a20db4a61c4a1e894c1e461b4; record id: use-case-diagnostic-rna-pathogen-detection; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 6b8b16df53f61fbf2ee9d4f65eb9863671985cd51f12fea5572b09972bce2aa5